Advanced search
Publication Cover
Degenerative Neurological and Neuromuscular Disease Volume 7, 2017 - Issue
Submit an article Journal homepage
74
Views
4
CrossRef citations to date
0
Altmetric
Review

Advances in the treatment of relapsing–remitting multiple sclerosis: the role of pegylated interferon β-1a

Kendra L Furber1 Laboratory of Molecular Cell Biology, [email protected];2 College of Pharmacy and Nutrition, [email protected];3 Neuroscience Research Cluster, University of Saskatchewan, [email protected]
,
Marina Van Agten1 Laboratory of Molecular Cell Biology, [email protected];2 College of Pharmacy and Nutrition, [email protected];3 Neuroscience Research Cluster, University of Saskatchewan, [email protected]
,
Charity Evans2 College of Pharmacy and Nutrition, [email protected];4 Cameco Multiple Sclerosis Neuroscience Research Center, City Hospital, [email protected]
,
Azita Haddadi2 College of Pharmacy and Nutrition, [email protected]
,
J Ronald Doucette3 Neuroscience Research Cluster, University of Saskatchewan, [email protected];4 Cameco Multiple Sclerosis Neuroscience Research Center, City Hospital, [email protected];5 Department of Anatomy and Cell Biology, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada
&
Adil J Nazarali1 Laboratory of Molecular Cell Biology, [email protected];2 College of Pharmacy and Nutrition, [email protected];3 Neuroscience Research Cluster, University of Saskatchewan, [email protected];4 Cameco Multiple Sclerosis Neuroscience Research Center, City Hospital, [email protected]Correspondence[email protected]
Pages 47-60 | Published online: 24 Mar 2017

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Carolyn H Goldschmidt & Le H Hua. (2020) Re-Evaluating the Use of IFN-β and Relapsing Multiple Sclerosis: Safety, Efficacy and Place in Therapy. Degenerative Neurological and Neuromuscular Disease 10, pages 29-38.
Read now

Articles from other publishers (3)

A.N. Boyko, K.Z. Bakhtiyarova, O.V. Boyko, V.A. Dudin, L.G. Zaslavskii, N.A. Malkova, E.V. Parshina, I.Ye. Poverennova, S.A. Sivertseva, N.A. Totolyan, S.G. Shchur, F.A. Khabirov, Z.A. Goncharova, M.N. Zakharova, D.D. Bolsun, A.V. Zinkina-Orikhan, Yu.N. Lin’kova, T.V. Chernovskaya & A.A. Porozova. (2023) Long-term Efficacy and Safety of Sampeginterferon-β1a in the Treatment of Relapsing Remitting Multiple Sclerosis: a Randomized, Double-Blind Clinical Trial 104-Week Results. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 123:2, pages 52.
Crossref
Ruizhen Liu, Zhiping Zhang, Yibing Chen, Junbo Liao, Yuchang Wang, Jingping Liu, Zhixiong Lin & Gelei Xiao. (2022) Choroid plexus epithelium and its role in neurological diseases. Frontiers in Molecular Neuroscience 15.
Crossref
Wylezinski, Gray, Polk, Harmata & SpurlockIIIIII. (2019) Illuminating an Invisible Epidemic: A Systemic Review of the Clinical and Economic Benefits of Early Diagnosis and Treatment in Inflammatory Disease and Related Syndromes. Journal of Clinical Medicine 8:4, pages 493.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.